Sharp Therapeutics closes C$ 1.37 million private placement at C$ 0.91/share

• Sharp Therapeutics closed a non-brokered private placement, raising C$ 1.37 million through 1,500,000 common shares priced at C$ 0.91.
• Proceeds earmarked for general working capital.
• Chairman William R. Newlin, via Newlin Investment Company 1, subscribed for US$ 200,000.45.
• Shares carry a four-month hold period plus one day.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sharp Therapeutics Corp. published the original content used to generate this news brief via Newsfile (Ref. ID: 202607290845NEWSFILECNPR____20260729_306997_1) on July 29, 2026, and is solely responsible for the information contained therein.